Literature DB >> 15688069

Proteolysis: from the lysosome to ubiquitin and the proteasome.

Aaron Ciechanover1.   

Abstract

How the genetic code is translated into proteins was a key focus of biological research before the 1980s, but how these proteins are degraded remained a neglected area. With the discovery of the lysosome, it was suggested that cellular proteins are degraded in this organelle. However, several independent lines of experimental evidence strongly indicated that non-lysosomal pathways have an important role in intracellular proteolysis, although their identity and mechanisms of action remained obscure. The discovery of the ubiquitin-proteasome system resolved this enigma.

Mesh:

Substances:

Year:  2005        PMID: 15688069     DOI: 10.1038/nrm1552

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  357 in total

1.  FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation.

Authors:  C Feng; F Yang; J Wang
Journal:  Cancer Gene Ther       Date:  2017-08-04       Impact factor: 5.987

2.  HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells.

Authors:  J I-Ju Leu; Julia Pimkina; Pooja Pandey; Maureen E Murphy; Donna L George
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

Review 3.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

4.  Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease.

Authors:  Eric B Dammer; Chan Hyun Na; Ping Xu; Nicholas T Seyfried; Duc M Duong; Dongmei Cheng; Marla Gearing; Howard Rees; James J Lah; Allan I Levey; John Rush; Junmin Peng
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

5.  Using bleach-chase to measure protein half-lives in living cells.

Authors:  Naama Geva-Zatorsky; Irina Issaeva; Avi Mayo; Ariel Cohen; Erez Dekel; Tamar Danon; Lydia Cohen; Yuvalal Liron; Uri Alon; Eran Eden
Journal:  Nat Protoc       Date:  2012-03-29       Impact factor: 13.491

Review 6.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 7.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

Review 8.  Integration of clearance mechanisms: the proteasome and autophagy.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-11-10       Impact factor: 10.005

9.  Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells.

Authors:  Hai-Tong Fang; Bo Zhang; Xiao-Fen Pan; Li Gao; Tao Zhen; Hong-Xia Zhao; Liang Ma; Jun Xie; Zi Liu; Xian-Jun Yu; Xin Cheng; Ting-Ting Feng; Feng-Xiang Zhang; Yong Yang; Zhong-Guo Hu; Guo-Qing Sheng; Yong-Long Chen; Sai-Juan Chen; Zhu Chen; Guang-Biao Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

10.  Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation.

Authors:  John Evankovich; Travis Lear; Alison Mckelvey; Sarah Dunn; James Londino; Yuan Liu; Bill B Chen; Rama K Mallampalli
Journal:  FASEB J       Date:  2017-05-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.